Coronavirus: Get complete details about the university's response to COVID-19.
The College of Pharmacy is a leader in cutting-edge pharmacological research, contributing to the advancement of the industry, providing an elite training ground for the next generation of researchers and, most importantly, transforming the lives of millions of people who rely on effective medication and treatment for a variety of diseases.
As part of a research institution of the highest caliber, the College of Pharmacy continues to attract exceptional research faculty who dedicate themselves to helping people by using research to develop more effective drugs, evaluate existing drugs and improve patient care.
We conduct research in a variety of focus areas and receive additional support through four on-site centers and facilities that provide
access to the technology and collaborative knowledge necessary for significant pharmacy
advancements and scientific breakthroughs.
Director Igor Roninson, Ph.D., is internationally recognized for cancer research, including his study of multi-drug resistance in cancer and chemotherapy-induced senescence in tumor cells. The Center for Translational Cancer Therapy provides a platform for the discovery and development of cancer drugs.
Simply stated, targeted therapeutics research aims to develop new and more effective classes of drugs against various diseases. Directed by Igor Roninson, Ph.D., the Center for Targeted Therapeutics also includes three resource cores and supports research projects led by junior faculty members.
Along with his team at the Medication Safety and Efficacy Center, Charlie Bennett, M.D., Ph.D., MPP, is studying ways to make drug information more consumer-friendly and creating new training tools for healthcare providers.
The following core facilities are sponsored in part by the COBRE Center for Translational Cancer Therapeutics:
Part of the Functional Genomics Core, and under the direction of Kim E. Creek, the Microarray Core Facility is a state-of-the-art facility that allows researchers to determine specific alterations in gene expression in various disease states, following exposure to drugs or chemicals.
Located in the Coker Life Sciences building at USC, and directed by Robert Doran and Chang-uk Lim, this facility provides training and services in microscopy, flow cytometry and quantitative PCR.
The Drug Discovery and Synthesis Core is directed by Patrick Woster at the Medical University of South Carolina (MUSC). This core advises and assists researchers with rational drug design, high-throughput screening and chemical synthesis.
Advice on the use of functional genomics for Targeted Therapeutics projects